News
Bayer launches new reversible contraception method
www.zenopa.com
Bayer's new reversible contraception method has been launched in Britain after receiving regulatory approval.
NICE nod for new Eylea indication - PharmaTimes
www.pharmatimes.com
“We are pleased that NICE has recognised the value of Eylea and the benefits that it can bring to patients and the clinical community,” said Lars Bruening, Bayer UK/Ireland's chief executive. “At Bayer we are committed to ensuring all eligible patients have access to Eylea in line with the market authorisation ...
Bayer's Eylea approved by NICE for myopic choroidal neovascularisation
www.zenopa.com
Bayer's Eylea has been recommended by NICE as a treatment for visual impairment due to myopic choroidal neovascularisation.
Bayer backs new mobile eye unit in Hampshire - PharmaTimes
www.pharmatimes.com
Will work with University Hospital Southampton NHS Foundation Trust on the service - News - PharmaTimes
sortiert nach Relevanz / Datum